Neo-adjuvant treatment for borderline and locally advanced pancreatic cancer: A single institution experience

Objectives Neo-adjuvant chemo-(radio-) therapy (NAT) is commonly accepted as part of the multimodality treatment for borderline/locally advanced pancreatic cancer (BR/LA-PC), however data on outcome from large surgical series is few. The aim of the study is to analyze the short and long-term outcome of patients with BR/LA-PC planned for NAT.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Elena Rangelova, Agnes Wefer, Saga Persson, Roberto Valente, Ralf Segersv ärd, Urban Arnelo, Marco Del Chiaro Tags: Session 4. Surgical issues of pancreatic tumor resection - free papers Source Type: research